Viewing Study NCT00453167


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-03-06 @ 12:03 PM
Study NCT ID: NCT00453167
Status: COMPLETED
Last Update Posted: 2010-07-12
First Post: 2007-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
Sponsor: National Cancer Center, Korea
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Small cell lung cancer View
None second-line therapy View